Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals

According to a report by CNBC… Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms. complete report is on link below. Source: https://www.cnbc.com/2026/09/21/chinese-biopharma-stocks-jump-as-us-plans-to-continue-drug-licensing-deals-.html